ClinicalTrials.gg
Sign In

Carcinoma, Squamous Cell clinical trials

The registry lists 627 studies for Carcinoma, Squamous Cell across more than 10 countries. 133 are recruiting or about to start. 181 of them are mainly about Carcinoma, Squamous Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Squamous Cell Carcinoma of Head and Neck: 3,115 studies, 903 open.

ClinicalTrials.gov finds 5,000 studies for Carcinoma, Squamous Cell. How that becomes 627 here

This page counts the studies the registry files under Carcinoma, Squamous Cell, and those it files under no condition that list Carcinoma, Squamous Cellthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 5,000Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −2,484Filed under a narrower condition, counted on its own pageSquamous Cell Carcinoma of Head and Neck 1,807 · Esophageal Squamous Cell Carcinoma 568
  3. −500List Carcinoma, Squamous Cell as a condition, but the registry did not file them under itMost often written as “Cutaneous Squamous Cell Carcinoma” (52), “Cervical Squamous Cell Carcinoma” (38), and “Squamous Cell Carcinoma of the Skin” (19). The registry filed 177 of them under no condition at all, and the others under other conditions only, most often Uterine Cervical Neoplasms (62) and Carcinoma, Basal Cell (35).
  4. −1,389Match it another way525 name it in the title, 121 in a keyword, and 743 by a synonym or other text the search reads.
  5. 627The count on this page

Get an email when these change. Save the Carcinoma, Squamous Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
263
Recruiting
100
Terminated
89
Status unknown
58
Active, not recruiting
50
Withdrawn
30

Phase

Phase 2
242
Phase 1
137
Phase 3
61
Early Phase 1
11
Phase 4
8

Where

United States
328
France
67
Canada
45
United Kingdom
39
China
35
Spain
34

Who runs them

M.D. Anderson Cancer Center (18) · Memorial Sloan Kettering Cancer Center (15) · Alpha Tau Medical LTD. (12) · UNC Lineberger Comprehensive Cancer Center (11) · National Cancer Institute (NCI) (9) · H. Lee Moffitt Cancer Center and Research Institute (9) · Vanderbilt-Ingram Cancer Center (8) · Merck Sharp & Dohme LLC (7)

What is being tested here

Drugs under test in Carcinoma, Squamous Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cisplatin5332
Docetaxel3220
Pembrolizumab3217
Nivolumab3111
Panitumumab309
Cemiplimab326
IRDye800303
Cetuximab2019
Carboplatin2014
Fluorouracil2010

Drug classes tested here Immune checkpoint inhibitors 16 open · Antimitotic agents 4 open · Antimetabolites 4 open · Tyrosine kinase inhibitors (TKIs) 3 open · Alkylating agents 2 open

Coming up

11phase 3 studies under way
55studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 100 Carcinoma, Squamous Cell studies recruiting now, 84 (84%) set no upper age limit and 8 (8%) stop at 75 or younger. 7 (7%) take children under 18. 1 (1%) are for women only and 1 (1%) for men only; 9 (9%) take healthy volunteers.

Recruiting studies that take each age, of 100
AgeWomenMen
107 (7%)7 (7%)
1895 (95%)95 (95%)
3098 (98%)97 (97%)
4098 (98%)98 (98%)
5098 (98%)98 (98%)
6599 (99%)99 (99%)
7597 (97%)97 (97%)
8589 (89%)90 (90%)

Across all 627 studies, recruiting or not: 10% stop at 75 or younger and 2% at 65; 7% take children; 2% are for women only and 1% for men only; 8% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Carcinoma, Squamous Cell studies take

Of 97 phase 2 interventional studies under Carcinoma, Squamous Cell, half reached primary completion within 61 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 140 mo32–62 · 42 studies——
Phase 1/262 mo51–105 · 27 studies——
Phase 261 mo37–82 · 97 studies—61 mo44–82 · 86 studies
Phase 342 mo32–91 · 21 studies——
Interventional, no phase81 mo27–137 · 53 studies——
Observational139 mo24–248 · 43 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting4

Results posted1

Stopped1

Newly registered4

Studies

Recruiting first, then most recently updated. Showing 50 of 627. Browse all 627 → or search them.